1.Teunis, PF, et al. Norwalk virus: how infectious is it? Journal of Medical Virology 2008; 80: 1468–1476.
2.Cannon, JL, et al. Surrogates for the study of norovirus stability and inactivation in the environment: a comparison of murine norovirus and feline calicivirus. Journal of Food Protection 2006; 69: 2761–2765.
3.WHO, FAO. Viruses in food: scientific advice to support risk management activities, 2008. Meeting Report. Microbiological Risk Assessment Series, no. 13.
4.Wheeler, JG, et al. Study of infectious intestinal disease in England: rates in the community, presenting to general practice, and reported to national surveillance. The Infectious Intestinal Disease Study Executive. British Medical Journal 1999; 318: 1046–1050.
5.Tam, CC, et al. Longitudinal study of infectious intestinal disease in the UK (IID2 study): incidence in the community and presenting to general practice. Gut 2012; 61: 69–77.
6.de Wit, MA, et al. Sensor, a population-based cohort study on gastroenteritis in the Netherlands: incidence and etiology. American Journal of Epidemiology 2001; 154: 666–674.
7.Kemmeren, JM, et al. Priority setting of foodborne pathogens: disease burden and costs of selected enteric pathogens. RIVM, 2006. Report No.: 330080001/2006.
8.Bruggink, L, Sameer, R, Marshall, J. Molecular and epidemiological characteristics of norovirus associated with community-based sporadic gastroenteritis incidents and norovirus outbreaks in Victoria, Australia, 2002–2007. Intervirology 2010; 53: 167–172.
9.Mead, PS, et al. Food-related illness and death in the United States. Emerging Infectious Diseases 1999; 5: 607–625.
10.van Asten, L, et al. Unspecified gastroenteritis illness and deaths in the elderly associated with norovirus epidemics. Epidemiology 2011; 22: 336–343.
11.Rondy, M, et al. Norovirus disease associated with excess mortality and use of statins: a retrospective cohort study of an outbreak following a pilgrimage to Lourdes. Epidemiology and Infection 2011; 139: 453–463.
12.Verhoef, L, et al. Emergence of new norovirus variants on spring cruise ships and prediction of winter epidemics. Emerging Infectious Diseases 2008; 14: 238–243.
13.Siebenga, JJ, et al. Phylodynamic reconstruction reveals norovirus GII.4 epidemic expansions and their molecular determinants. PLoS Pathogens 2010; 6: e1000884.
14.Havelaar, AH, et al. Disease burden in The Netherlands due to infections with Shiga toxin-producing Escherichia coli O157. Epidemiology and Infection 2004; 132: 467–484.
16.de Wit, MA, et al. Gastroenteritis in sentinel general practices. The Netherlands. Emerging Infectious Diseases 2001; 7: 82–91.
17.Pelt van, W, et al. Trends in gastroenteritis in the Netherlands, 2008 and 2009 [in Dutch]. Bilthoven: RIVM, 2010.
18.Friesema, IH, et al. Etiology of acute gastroenteritis in children requiring hospitalization in the Netherlands. European Journal of Clinical Microbiology and Infectious Diseases 2012; 31: 405–415.
19.Koch, J, et al. Norovirus infections in Germany [in German]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2006; 49: 296–309.
20.Murray, CJ. Quantifying the burden of disease: the technical basis for disability-adjusted life years. Bulletin of the World Health Organization 1994; 72: 429–445.
21.Haagsma, JA, et al. Disability adjusted life years and minimal disease: application of a preference-based relevance criterion to rank enteric pathogens. Population Health Metrics 2008; 6: 7.
22.Svraka, S, et al. Etiological role of viruses in outbreaks of acute gastroenteritis in The Netherlands from 1994 through 2005. Journal of Clinical Microbiology 2007; 45: 1389–1394.
23.van Duynhoven, YT, et al. A one-year intensified study of outbreaks of gastroenteritis in The Netherlands. Epidemiology and Infection 2005; 133: 9–21.
24.Cunningham, CJ, et al. Survival of patients discharged to long term care. Irish Medical Journal 2008; 101: 305–307.
25.Hakkaart-van Roijen, L, Tan, SS, Bouwmans, CAM.Guideline for cost research – methods and standardized costs for economic evaluations in health care. Diemen, The Netherlands: Board of Health Insurance, 2010 [in Dutch].
26.Havelaar, AH, et al. Attribution of foodborne pathogens using structured expert elicitation. Foodborne Pathogens and Disease 2008; 5: 649–659.
27.Verhoef, L, et al. Selection tool for foodborne norovirus outbreaks. Emerging Infectious Diseases 2009; 15: 31–38.
28.Scallan, E, et al. Foodborne illness acquired in the United States – major pathogens. Emerging Infectious Diseases 2011; 17: 7–15.
29.Haagsma, JA, et al. Disease burden of post-infectious irritable bowel syndrome in The Netherlands. Epidemiology and Infection 2010; 138: 1650–1656.
30.Harris, JP, et al. Deaths from norovirus among the elderly, England and Wales. Emerging Infectious Diseases 2008; 14: 1546–1552.
31.Kirk, MD, et al. Surveillance for outbreaks of gastroenteritis in long-term care facilities, Australia, 2002–2008. Clinical Infectious Diseases 2010; 51: 907–914.
32.Doyle, TJ, Glynn, MK, Groseclose, SL. Completeness of notifiable infectious disease reporting in the United States: an analytical literature review. American Journal of Epidemiology 2002; 155: 866–874.
33.Friesema, IH, et al. Norovirus outbreaks in nursing homes: the evaluation of infection control measures. Epidemiology and Infection 2009; 137: 1722–1733.
34.Enserink, R, et al. Absence of influenza A(H1N1) during seasonal and pandemic seasons in a sentinel nursing home surveillance network in the Netherlands. Journal of the American Geriatrics Society 2011; 59: 2301–2305.
35.Lopman, BA, et al. Clinical manifestation of norovirus gastroenteritis in health care settings. Clinical Infectious Diseases 2004; 39: 318–324.
36.Chen, SY, et al. Norovirus infection as a cause of diarrhea-associated benign infantile seizures. Clinical Infectious Diseases 2009; 48: 849–855.
37.Ito, S, et al. Norovirus-associated encephalopathy. Pediatric Infectious Disease Journal 2006; 25: 651–652.
38.Marshall, JK, et al. Postinfectious irritable bowel syndrome after a food-borne outbreak of acute gastroenteritis attributed to a viral pathogen. Clinical Gastroenterology and Hepatology 2007; 5: 457–460.
39.O'Brien, S. The challenge of estimating the burden of an underreported disease. In: Koopmans, M, Cliver, DO, Bosch, A, eds. Food-borne Viruses. Washington: ASM Press, 2008, pp. 87–116.
40.de Wit, MA, Koopmans, MP, van Duynhoven, YT. Risk factors for norovirus, Sapporo-like virus, and group A rotavirus gastroenteritis. Emerging Infectious Diseases 2003; 9: 1563–1570.